Hmga1 null mice are less susceptible to chemically induced skin carcinogenesis

European Journal of Cancer

Volumn 44, Issue 2, 2008, Pages 318-325

  Visone, Rosa ^a,b,f   Iuliano, Rodolfo ^a,b   Palmieri, Dario ^a   Server, Ilter Nurettin ^b   Chiappetta, Gennaro ^c   De Martino, Ivana ^a,b   Fedele, Monica ^d   Costinean, Stefan ^b   Oberyszyn, Tatiana M ^e   Kusewitt, Donna F ^e   Croce, Carlo M ^b   Fusco, Alfredo ^a,f  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d CNR   (Italy)

^e OHIO STATE UNIVERSITY   (United States)

^f CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Carcinoma; HMGA1; Papilloma; Skin carcinogenesis; TPA

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN RAB11A; RAB PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; KNOCKOUT MOUSE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN PAPILLOMA; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HMGA PROTEINS; KERATINOCYTES; MICE; MICE, KNOCKOUT; PAPILLOMA; PROTO-ONCOGENE PROTEINS C-FOS; RAB GTP-BINDING PROTEINS; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 38349059772     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.11.017     Document Type: Article

References (31)

1. Fedele M., Battista S., Manfioletti G., Croce C.M., Giancotti V., and Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22 (2001) 1583-1591
2. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277 (2001) 63-81
3. Thanos D., and Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83 (1995) 1091-1100
4. Chiappetta G., Avantaggiato V., Visconti R., et al. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13 (1996) 2439-2446
5. Fedele M., Fidanza V., Battista S., et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 66 (2006) 2536-2543
6. Foti D., Chiefari E., Fedele M., et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 11 (2005) 765-773
7. Schoenmakers E.F., Wanschura S., Mols R., Bullerdiek J., Van den Berghe H., and Van de Ven W.J. Recurrent rearrangements in the high mobility group protein gene, HMGI- C, in benign mesenchymal tumors. Nat Genet 10 (1995) 436-444
8. Ashar H.R., Fejzo M.S., Tkachenko A., et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82 (1995) 57-65
9. Giancotti V., Pani B., D'Andrea P., et al. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c- myc and polyoma middle T genes. Embo J 6 (1987) 1981-1987
10. Giancotti V., Buratti E., Perissin L., et al. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 184 (1989) 538-545
11. Chiappetta G., Bandiera A., Berlingieri M.T., et al. The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene 10 (1995) 1307-1314
12. Fedele M., Bandiera A., Chiappetta G., et al. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res 56 (1996) 1896-1901
13. Abe N., Watanabe T., Masaki T., et al. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res 60 (2000) 3117-3122
14. Bandiera A., Bonifacio D., Manfioletti G., et al. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res 58 (1998) 426-431
15. Liu W.M., Guerra-Vladusic F.K., Kurakata S., Lupu R., and Kohwi-Shigematsu T. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. Cancer Res 59 (1999) 5695-5703
16. Masciullo V., Baldassarre G., Pentimalli F., et al. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Carcinogenesis 24 (2003) 1191-1198
17. Donato G., Martinez Hoyos J., Amorosi A., et al. High mobility group A1 expression correlates with the histological grade of human glial tumors. Oncol Rep 11 (2004) 1209-1213
18. Wood L.J., Maher J.F., Bunton T.E., and Resar L.M. The oncogenic properties of the HMG-I gene family. Cancer Res 60 (2000) 4256-4261
19. Fedele M., Pentimalli F., Baldassarre G., et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 24 (2005) 3427-3435
20. Berlingieri M.T., Pierantoni G.M., Giancotti V., Santoro M., and Fusco A. Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 21 (2002) 2971-2980
21. Scala S., Portella G., Fedele M., Chiappetta G., and Fusco A. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci U S A 97 (2000) 4256-4261
22. Rajeswari M.R., Singh D., Jain A., and Ray R. Elevated levels of high-mobility-group chromosomal proteins, HMGA1, in murine skin carcinoma. Cancer Lett 1 (2001) 93-99
23. Ogram S.A., and Reeves R. Differential regulation of a multiprotein gene. Selective 12-O-tetradecanoylphorbol-13 acetate induction of a single transcription start site in the HMG-I/Y gene. J Biol Chem 23 (1995) 14235-14242
24. Berlingieri M.T., Manfioletti G., Santoro M., et al. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 15 (1995) 1545-1553
25. Chin M.T., Pellacani A., Wang H., et al. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem 273 (1998) 9755-9760
26. Gebhardt C., Breitenbach U., Richter K.H., et al. c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis. Am J Pathol 167 (2005) 243-253
27. Saez E., Rutberg S.E., Mueller E., et al. c-fos is required for malignant progression of skin tumors. Cell 82 5 (1995) 721-732
28. Chiappetta G., Manfioletti G., Pentimalli F., et al. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases. Int J Cancer 91 (2001) 147-151
29. Scala S., Portella G., Vitagliano D., et al. HMGI-C gene expression is not required for in vivo thyroid cell transformation. Carcinogenesis 22 (2001) 251-256
30. Adair J.E., Kwon Y., Dement G.A., Smerdon M.J., and Reeves R. Inhibition of nucleotide excision repair by high mobility group protein HMGA1. J Biol Chem 280 (2005) 32184-32192
31. Baldassarre G., Belletti B., Battista S., et al. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. Oncogene 24 (2005) 6809-6819